Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Cell Mol Med ; 22(6): 3133-3138, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29566294

RESUMEN

Serine racemase (SR) is an enzyme that catalyses the synthesis of d-serine, an endogenous coagonist for N-methyl-D-aspartate (NMDA)-type glutamate receptor in the central nervous system. Our previous study demonstrated that SR was expressed in the epidermis of wild-type (WT) mice but not in SR knockout (KO) mice. In addition, SR immune-reactivity was only found in the granular and cornified layers of the epidermis in WT mice. These findings suggested that SR is involved in the differentiation of epidermal keratinocytes and the formation of the skin barrier. However, its role in skin barrier dysfunction such as atopic dermatitis (AD) remains elusive. AD is a chronic inflammatory disease of skin, and the clinical presentation of AD has been reported to be occasionally associated with psychological factors. Therefore, this study examined the content of d-serine in stratum corneum in AD patients and healthy controls using a tape-stripping method. Skin samples were collected from the cheek and upper arm skin of AD patient's lesion and healthy individuals. The d-serine content was significantly increased in the involved skin of AD in comparison with healthy individuals. An immunohistochemical analysis also revealed an increased SR expression in the epidermis of AD patients. Furthermore, the SR expression in cultured human keratinocytes was significantly increased by the stimulation with tumour necrosis factor -α or macrophage migration inhibitory factor. Taken together, these findings suggest that d-serine expressed particularly strongly in AD lesional skin and that the SR expression in the keratinocytes is linked to inflammatory cytokines.


Asunto(s)
Dermatitis Atópica/genética , Inflamación/genética , Racemasas y Epimerasas/genética , Piel/enzimología , Adulto , Animales , Diferenciación Celular/genética , Citocinas/genética , Dermatitis Atópica/enzimología , Dermatitis Atópica/patología , Epidermis/enzimología , Epidermis/patología , Femenino , Regulación Enzimológica de la Expresión Génica , Humanos , Inflamación/enzimología , Inflamación/patología , Queratinocitos/enzimología , Queratinocitos/patología , Macrófagos/enzimología , Macrófagos/metabolismo , Masculino , Ratones , Persona de Mediana Edad , Racemasas y Epimerasas/metabolismo , Receptores de N-Metil-D-Aspartato/genética , Serina/metabolismo , Piel/patología , Adulto Joven
2.
J Dermatol ; 45(5): 618-621, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29473202

RESUMEN

The usefulness of stratum corneum neutrophil gelatinase-associated lipocalin and stratum corneum galectin-7 as biomarkers of acne vulgaris was studied. A comparison of neutrophil gelatinase-associated lipocalin levels on the cheeks of patients with acne vulgaris at the start of the study and at the time of symptom improvement showed a significant decrease. On the other hand, the galectin-7 levels at the time of symptom improvement were significantly higher than those at the start of the study. Therefore, because the inflammation in the epidermis and hair follicles was reduced after therapy, as a result of the solution of the inflammatory eruptions caused by acne vulgaris, the neutrophil gelatinase-associated lipocalin level also showed a significant decrease after therapy. These results suggest that stratum corneum neutrophil gelatinase-associated lipocalin may be useful as an objective biomarker of changes in acne vulgaris symptoms.


Asunto(s)
Acné Vulgar/diagnóstico , Fármacos Dermatológicos/uso terapéutico , Galectinas/análisis , Lipocalina 2/análisis , Acné Vulgar/tratamiento farmacológico , Acné Vulgar/patología , Administración Cutánea , Administración Oral , Adolescente , Adulto , Biomarcadores/análisis , Mejilla , Epidermis/patología , Femenino , Humanos , Masculino , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Resultado del Tratamiento , Adulto Joven
3.
J Cosmet Dermatol ; 16(4): e37-e41, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28371078

RESUMEN

BACKGROUND AND AIMS: Pruritus frequently reduces quality of life (QOL) in patients with senile xerosis. This study investigated the moisturizing and antipruritic effects of a topical emollient containing a diethylene glycol/dilinoleic acid copolymer (D/DC) in patients with pruritic senile xerosis. METHODS: This single-blind study involved 50 subjects, aged 50-75 years. Patients were randomized to self-applied treatment of the lower legs with 10% (n = 20) or 20% (n = 20) D/DC-containing cream, white petrolatum (n = 5), or no treatment (n = 5) thrice daily for four weeks. Clinical scores of skin dryness and scratch marks, skin conductance, and Skindex-16 were evaluated before and after treatment. The degree of pruritus was evaluated by visual analog scale (VAS) score once a week. RESULTS: Patients treated with 10% and 20% D/DC showed significant improvements in skin dryness and scratch mark scores, as well as increased skin conductance, compared with the untreated group, whereas white petrolatum treatment improved only skin dryness scores. Moreover, patients treated with 20% D/DC showed significant improvements in skin dryness scores and skin conductance compared with white petrolatum treatment. The VAS scores in the D/DC-treated and white petrolatum-treated groups were significantly lower than in the untreated group, being particularly lower after one week of treatment with 20% D/DC. CONCLUSION: Topical application of an emollient containing D/DC is effective in improving skin dryness and pruritus in patients with senile xerosis.


Asunto(s)
Emolientes/uso terapéutico , Glicoles de Etileno/uso terapéutico , Dermatosis de la Pierna/tratamiento farmacológico , Ácido Linoleico/uso terapéutico , Prurito/tratamiento farmacológico , Envejecimiento de la Piel , Enfermedades de la Piel/tratamiento farmacológico , Anciano , Femenino , Respuesta Galvánica de la Piel/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Vaselina/uso terapéutico , Método Simple Ciego , Escala Visual Analógica
5.
Arch Dermatol Res ; 307(10): 925-35, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26498291

RESUMEN

DJ-1 is a multifunctional protein associated with Parkinson's disease and plays a significant role in protecting nerve cells from oxidative stress. DJ-1 is expressed in the skin, although its function there is unknown. In this study, we investigated DJ-1 function in keratinocytes. DJ-1 was induced by H2O2 exposure and UV irradiation in keratinocytes. DJ-1 knockdown with small interfering RNA (siRNA) increased reactive oxygen species (ROS) and lactate dehydrogenase (LDH) release after UVB irradiation, suggesting that DJ-1 reduces ROS and might protect skin cells from UV damage in vitro. To investigate the in vivo role of DJ-1 in the skin, we determined DJ-1 levels in human stratum corneum samples obtained by the tape-stripping method. DJ-1 levels in the stratum corneum (scDJ-1) correlated with total antioxidant capacity. We also examined the effect of scDJ-1 on changes in skin after UVB irradiation. DJ-1 was elevated in SC from the upper arm 1 to 2 weeks after UVB irradiation. One day after UVB irradiation, L* (brightness) and a* (redness) values, indicators of skin color, were altered regardless of scDJ-1 expression. However, these values recovered more quickly in subjects with high scDJ-1 expression than in those with low scDJ-1 expression. These data suggest that DJ-1 in skin plays a significant role in protection against UV radiation and oxidative stress, and that DJ-1 levels in the SC might be an indicator of antioxidative defense against UV-induced damage.


Asunto(s)
Antioxidantes/metabolismo , Epidermis/efectos de la radiación , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Queratinocitos/metabolismo , Proteínas Oncogénicas/metabolismo , Estrés Oxidativo/fisiología , Rayos Ultravioleta/efectos adversos , Adolescente , Adulto , Biomarcadores/análisis , Línea Celular , Citocinas/biosíntesis , Citoprotección/fisiología , Epidermis/patología , Femenino , Humanos , Peróxido de Hidrógeno/efectos adversos , Peróxido de Hidrógeno/metabolismo , Péptidos y Proteínas de Señalización Intracelular/genética , Queratinocitos/efectos de la radiación , L-Lactato Deshidrogenasa/metabolismo , Masculino , Persona de Mediana Edad , Proteínas Oncogénicas/genética , Proteína Desglicasa DJ-1 , Interferencia de ARN , ARN Interferente Pequeño/genética , Pigmentación de la Piel , Adulto Joven
6.
Exp Dermatol ; 23(10): 764-6, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25056219

RESUMEN

Different biomarkers are used to evaluate the severity of atopic dermatitis (AD); however, it remains difficult to determine the severity of localized skin lesions. MIF plays an essential role in the pathophysiology of skin inflammation. To establish whether the MIF level in the stratum corneum (SC) serves as a marker of the severity of AD lesions, we examined the SC MIF (scMIF) levels in AD patients. The SC of the cheek, neck and upper arm skin was collected using tape stripping, and the scMIF levels were measured. Consequently, the scMIF levels were found to be significantly higher in the involved skin lesions than the uninvolved areas within the same patient. Moreover, the scMIF levels were significantly correlated with the severity of local skin lesions. These findings suggest that the scMIF level can be used as an effective marker for evaluating the local severity of AD.


Asunto(s)
Dermatitis Atópica/metabolismo , Oxidorreductasas Intramoleculares/metabolismo , Factores Inhibidores de la Migración de Macrófagos/metabolismo , Adolescente , Adulto , Biomarcadores/sangre , Biomarcadores/metabolismo , Estudios de Casos y Controles , Dermatitis Atópica/sangre , Dermatitis Atópica/patología , Epidermis/metabolismo , Epidermis/patología , Femenino , Humanos , Oxidorreductasas Intramoleculares/sangre , Factores Inhibidores de la Migración de Macrófagos/sangre , Masculino , Persona de Mediana Edad , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA